9 results
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
COVID-19 - Subpleural ... Consolidations on Lung ... conserve valuable PPEs ... #clinical #lung ... #ultrasound #pulmonary
Pulmonary Infarct with Subpleural Consolidation on Lung POCUS
PoCUS shows small R pleural effusion & subpleural consolidation-->lowered
Pulmonary Infarct ... Consolidation on Lung ... small R pleural effusion ... ended up having a PE ... #POCUS #clinical
Day 10 after COVID diagnosis. Less tired, but more cough, ageusia & anosmia. No dyspnea or
No fever. ... yaletung #Subpleural ... #COVID19 #clinical ... #lung #ultrasound ... #pulmonary #BLines
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
absence of intrinsic lung ... shunt (Type 2) Clinical ... on radioactive lung ... or pulmonary angiography ... ) on room air Treatment
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia - Clinical ... cough, dyspnea, fever ... Rare: pleural effusions ... Organizing Pneumonia Treatment ... Pneumonia #COP #BOOP #pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Active TB: • Fever ... assay (IGRA) • PPD ... Tuberculosis Treatment ... Initiating Treatment
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Plexiform-lesion formation Clinical ... 6 months after PE ... • Ventilation-perfusion ... lung scanning showing ... Bypass Other Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Active TB: • Fever ... assay (IGRA) • PPD ... Tuberculosis Treatment ... Initiating Treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... thickening or effusion ... , INC risk PE, Pulmonary ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment